Circio debuts proof-of-concept for circVec gene therapy at ASGCT 2024
BioPharma Reporter
MAY 13, 2024
Circio, a biotech firm specializing in circular RNA-based gene therapy, has unveiled two posters showcasing in vivo proof-of-concept for its circVec platform at ASGCT 2024.
Let's personalize your content